But this time his company is too small to buy a titan like Merck, and the joint venture could discourage buyers:It contains a "poison pill" clause that gives Merck the right to buy Schering-Plough's share of the partnership if Schering-Plough is acquired.

FORBES: Pills and Poker

But Schering-Plough will have to share those revenues with Merck, its marketing partner, which also has the option to buy the entire joint venture should Schering-Plough ever merge.

ECONOMIST: Can Fred Hassan cure Schering-Plough?

Schering-Plough reported earnings per share of 29 cents, excluding items.

FORBES: Lilly's And Schering's Blockbuster Hangovers

The resulting drop in the share price of Schering-Plough had an upside.

FORBES: Merck Could Return To Greatness If CEO Can Leave His Own Past Behind

Better take the hit over a broken pledge ( and Plaid know their fair share about that sort of thing too) than plough more money into a pretty expensive fig leaf, seems to be their take.

BBC: A health check on Labour pledges

Merck and Schering-Plough both beat analyst projections for adjusted earnings by a whopping 8 cents per share on sales of cholesterol drug Vytorin, which they sell together, and separate allergy blockbusters Singular and Nasonex.

FORBES: Magazine Article

Schering-Plough at a meeting of analysts today reported second-quarter earnings of 43 cents per share, flat compared to a year ago.

FORBES: Magazine Article

The editorial spells more trouble for Vytorin and its sister drug, Zetia--which share an active ingredient--and for their makers, Merck and Schering-Plough.

FORBES: Magazine Article